Cargando…
Omalizumab and unmet needs in severe asthma and allergic comorbidities in Japanese children
Childhood asthma is one condition within a family of allergic diseases, which includes allergic rhinitis, atopic dermatitis, and food allergy, among others. Omalizumab is an anti-IgE antibody therapy that was approved in Japan for children with asthma and added to the Japanese pediatric asthma guide...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365659/ https://www.ncbi.nlm.nih.gov/pubmed/30740355 http://dx.doi.org/10.5415/apallergy.2019.9.e7 |